Prostate

Author: Mikael Häggström [note 1]

TURP: Gross processing

For fragments obtained from transurethral resection of the prostate (TURP):[1]

  • Weigh and measure tissue aggregate in 3 dimensions.
  • If weight is less than or equal to 12 gm: Submit entirely in biopsy bags (usually approximately 12 cassettes).
  • If weight is more than 12 gm: Submit 12 grams in biopsy bags, and 1 additional cassette per each additional 5 grams.

Prostatectomy: Gross processing

  • For orientation, apply ink or make a cut to one half of the specimen, and possibly a different one to the other side.[2]
Prostate cutting

The transverse slices may be cut into quadrants if exceeding laboratory capacity.

  See also: General notes on gross processing


Most common targets

Evaluation

Screening method

  • Before microscopy, look at each microscopy slide by eye, to plan the microscopy screening so as to not miss peripheral fragments.
  • Screen at low power, and switch to high power when encountering glandular structures that can not otherwise be cleared. Look in particular for those surrounding nerves.
  • At least if no cancer is seen, also look for inflammation.[notes 1]

Characteristics of adenocarcinoma

Relatively common and highly specific findings of prostatic adenocarcinoma
[3]
Specific but relatively rare signs of adenocarcinoma
[notes 2]

On biopsies, look in particular near the tips for perineural invasion, as it is most likely seen by the capsule. Glands adjacent to and indenting nerves is not sufficient as a diagnostic criterion by itself. Glands partially surrounding a nerve is an indication of carcinoma.[4]

  • Collagenous micronodules for acinar adenocarcinoma[3]
  • Angiolymphatic invasion[3]
  • Extraprostatic extension,[3] which in biopsies can be diagnosed when tumor cells are located in fatty tissue.
Less specific findings
  • Prominent nucleoli[3]
  • Nuclear enlargement

Precancerous lesions

Histopathology of high-grade prostatic intraepithelial neoplasia (HGPIN), annotated.jpg

In case of only less specific findings, consider a Prostatic intraepithelial neoplasia (PIN) or an atypical small acinar proliferation (ASAP).

A PIN is where acini are architecturally benign, but individual cells display atypia. In high-grade PIN (HGPIN), the changes are similar to those of prostate cancer, whereas in low-grade (LGPIN) the changes are milder. Most pathologists do not report the presence of LGPIN.[7]

An ASAP is a lesion that is probably carcinoma but either lacks definitive diagnostic features, or is too small to be certain (see image below).[8] It should not be used for benign lesions that are just unusual looking.[8] In uncertain cases, a diagnosis of adenocarcinoma can be excluded by immunohistochemical detection of basal cells (or confirmed by absence thereof),[3] such as using the PIN-4 cocktail of stains (which consists of P504S, p63 and high-molecular-weight keratins (HMWK) such as CK5 and CK14).

Picture above compares a PIN-4 immunohistochemistry of benign gland (left) and adenocarcinoma (right) using PIN-4. The adenocarcinoma lacks the basal epithelial cells (stained dark brown by p63 and HMWK). Also, in PIN-4 stained samples, adenocarcinoma cells generally display red cytoplasms (stained by AMACR, also known as P504S), while benign glands do not.


Common normal findings

  • Infoldings in prostate glands.
  • Rectum tissue, by transrectal approach such as biopsies.

Reporting

Example in a normal biopsy:

(Prostate, right base, needle biopsy:)

Benign prostate tissue.

See Prostate adenocarcinoma article for related reporting.

Notes

  1. ↑ Inflammation can explain for example a high PSA value in the absence of adenocarcinoma, so its reporting is usually only needed in such cases.
  2. ↑ "Rare" here refers to prevalence at least in core biopsies.(Cruz 2016)
  1. ↑ For a full list of contributors, see article history. Creators of images are attributed at the image description pages, seen by clicking on the images. See Patholines:Authorship for details.

Main page

References

  1. ↑ Nicole Cipriani. Prostate: TURP. Gross Pathology Manual - The University of Chicago Department of Pathology.
  2. ↑ Monica Dahlgren, Janne Malina, Anna Måsbäck, Otto Ljungberg. Stora utskärningen. KVAST (Swedish Society of Pathology). Retrieved on 2019-09-26.
  3. ↑ 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 Cruz, Andrea O.; Santana, Amanda L. S.; Santos, Andréia C.; Athanazio, Daniel A. (2016). "Frequency of the morphological criteria of prostate adenocarcinoma in 387 consecutive prostate needle biopsies: emphasis on the location and number of nucleoli ". Jornal Brasileiro de Patologia e Medicina Laboratorial. doi:10.5935/1676-2444.20160018. ISSN 1676-2444. 
    Attribution 4.0 International (CC BY 4.0) license
  4. ↑ 4.0 4.1 4.2 Robert V Rouse MD. Prostatic Adenocarcinoma. Stanford Medical School. Last update 2/2/16
  5. ↑ Svatek, R S; Karam, J A; Rogers, T E; Shulman, M J; Margulis, V; Benaim, E A (2007). "Intraluminal crystalloids are highly associated with prostatic adenocarcinoma on concurrent biopsy specimens ". Prostate Cancer and Prostatic Diseases 10 (3): 279–282. doi:10.1038/sj.pcan.4500954. ISSN 1365-7852. 
  6. ↑ Image by Mikael Häggström, MD. Reference for features:
    - Margaret Sanders, M.B.B.Ch., Murali Varma, M.B.B.S.. High grade prostatic intraepithelial neoplasia (HGPIN). Pathology Outlines. Last author update: 23 February 2021
  7. ↑ Stanley A Brosman, MD. Precancerous Lesions of the Prostate. Medscape. Updated: Feb 26, 2020
  8. ↑ 8.0 8.1 . Prostatic Adenocarcinoma - Atypical Small Acinar Proliferation (ASAP). Stanford Medical School. Retrieved on 2020-09-14.
  9. ↑ Image by Mikael Häggström, MD. Reference for findings: Faryal Shoaib, M.D., Chinedum Okafor, M.D., Y. Albert Yeh, M.D., Ph.D.. Anatomy & histology-seminal vesicles / ejaculatory duct. Pathology Outlines. Last staff update: 20 November 2023

Image sources